Iwama I, Yoshida M, Miyazawa A, Hara T, et al. Ustekinumab Offers Long-Term Clinical Remission With Safety in Very Early-Onset Inflammatory Bowel Disease. Inflamm Bowel Dis 2024 Apr 8:izae078. doi: 10.1093.
PMID: 38588461